Teva Pharmaceutical Industries Ltd
TASE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd Logo
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Watchlist
Price: 10 030 ILS -0.89% Market Closed
Market Cap: 112.9B ILS

Wall Street
Price Targets

TEVA Price Targets Summary
Teva Pharmaceutical Industries Ltd

There are no price targets for TEVA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Teva Pharmaceutical Industries Ltd Competitors:
Price Targets
MANKIND
Mankind Pharma Ltd
24% Upside
INDOCO
Indoco Remedies Ltd
24% Upside
LUPIN
Lupin Ltd
11% Upside
000513
Livzon Pharmaceutical Group Inc
29% Upside
ELAN
Elanco Animal Health Inc
15% Upside
AXSM
Axsome Therapeutics Inc
21% Upside
ZTS
Zoetis Inc
29% Upside
MRK
Merck & Co Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Teva Pharmaceutical Industries Ltd

For the last 13 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's revenue is -1%. The projected CAGR for the next 3 years is 2%.

-1%
Past Growth
2%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Teva Pharmaceutical Industries Ltd

For the last 13 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -1%. The projected CAGR for the next 3 years is 11%.

-1%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Net Income
Forecast

Net Income Estimate
Teva Pharmaceutical Industries Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TEVA's stock price target?
Not Available

TEVA doesn't have any price targets made by Wall Street professionals.

What is Teva Pharmaceutical Industries Ltd's Revenue forecast?
Projected CAGR
2%

For the last 13 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's revenue is -1%. The projected CAGR for the next 3 years is 2%.

What is Teva Pharmaceutical Industries Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Teva Pharmaceutical Industries Ltd's operating income is -1%. The projected CAGR for the next 3 years is 11%.

Back to Top